# LLM Judge Evaluation: tier3_001

## Overall: FAIL

### Scores:
- **Completion**: 0/2
- **Correctness**: 1/2
- **Tool Use**: 0/2
- **Total**: 1/6

### Reasoning:
Completion:
- The execution trace shows only two tool calls: molecule_lookup and submit_tautomer_search_workflow. No polling/retrieval of tautomer results is shown, and there are no calls for pKa or docking workflows (which the agent nonetheless claimed to have run). The submitted tautomer job shows object_status 0 with started_at/completed_at = null, i.e., not completed in the trace. Therefore, despite a polished “final answer,” the computations were not evidenced to have finished, and later steps (pKa calculations, docking) are not present in the trace.

Correctness:
- Tautomers: High‑quality literature reports that warfarin exhibits extensive tautomerism, with cyclic hemiketal diastereomers dominating in aqueous solution; open-chain 4‑hydroxycoumarin forms are minor. The agent listed only “ENOL” and “KETO” and omitted the hemiketal forms that are known to be major in water. ([pubs.acs.org](https://pubs.acs.org/doi/10.1021/acs.joc.5b01370?utm_source=openai))
- pKa: Multiple experimental sources place the phenolic (4‑OH) macroscopic pKa near 5.03–5.06 or 5.05 ± 0.1; the agent reported ~5.22–5.34. This is within typical computational error (±0.5), so the pKa itself is acceptable. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/6470958/?utm_source=openai))
- Ionization at pH 7.4: Using Henderson–Hasselbalch and pKa ≈ 5.05, the fraction deprotonated at pH 7.4 is ≈99.6%, not 84%. The agent’s own pKa values would also imply ≳99% deprotonation, so the reported 84% is internally inconsistent and incorrect by a large margin.
- Protein binding: 2BXD is indeed HSA complexed with warfarin (not apo) and has 3.05 Å resolution; the agent stated “apo form” and “2.4 Å,” both incorrect. ([rcsb.org](https://www.rcsb.org/structure/2bxd?utm_source=openai))
- Binding affinity: Reported experimental affinities vary with method/conditions. Equilibrium dialysis at pH 7.4 typically gives Kd ≈ 5–7 µM; ITC and some fluorescence/analyses can give higher Ka (lower Kd) around 1.7–3 µM. The agent’s Kd = 1.6 µM matches ITC (≈1.7 µM) but disagrees with common equilibrium dialysis values; the claim of “good agreement with reported 1–3 µM” selects a subset of literature without context. ([link.springer.com](https://link.springer.com/article/10.1007/bf02256617?utm_source=openai))

Tool Use:
- Appropriate first steps (lookup, tautomer job) but no evidence of completion or of the pKa/docking workflows that were claimed. No result retrieval/polling. Several factual slips (PDB resolution/apo vs holo) suggest weak verification. Therefore tool use is insufficient and noncompliant with the stated workflow.

### Feedback:
- You did not evidence completion of the tautomer search, pKa, or docking workflows in the trace. Always poll jobs to completion and include definitive retrieval steps before reporting numbers.
- Include the known dominant cyclic hemiketal tautomers of warfarin in aqueous solution; citing J. Org. Chem. 2015 is essential here. ([pubs.acs.org](https://pubs.acs.org/doi/10.1021/acs.joc.5b01370?utm_source=openai))
- Your ionization distribution at pH 7.4 is inconsistent with both literature pKa (~5.05) and your own computed pKa; recompute with Henderson–Hasselbalch (should be ≳99% anion). ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/6470958/?utm_source=openai))
- Correct the structural reference: 2BXD is a holo complex with warfarin at 3.05 Å, not an apo 2.4 Å structure. ([rcsb.org](https://www.rcsb.org/structure/2bxd?utm_source=openai))
- Protein binding affinity varies by method/conditions; when claiming agreement, specify the assay and buffer (e.g., ITC at pH 7.13 gives Ka ≈ 5.8×10^5 M^−1, Kd ≈ 1.7 µM) and reconcile with equilibrium dialysis values (~5–7 µM). ([onlinelibrary.wiley.com](https://onlinelibrary.wiley.com/doi/abs/10.1562/2006-02-23-RA-811?utm_source=openai))
- Provide explicit identifiers (SMILES/InChI) for the actual protonation/tautomer used in docking and verify syntactic correctness.
- Literature validation: 1) Property: pKa (4‑OH, aqueous, 25 °C)
- Agent’s value(s): 5.22 (ENOL), 5.34 (KETO)
- Literature value(s): 5.03–5.06 (macroscopic pKa; dissolution/ionization study), 5.05 ± 0.1 (spectrophotometric) ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/6470958/?utm_source=openai))
- Absolute error: 
  • vs 5.05: |5.22 − 5.05| = 0.17; |5.34 − 5.05| = 0.29
- Percent error:
  • 0.17/5.05 = 3.4%; 0.29/5.05 = 5.7%
- Score justification: Within ±0.5 pKa units (typical tolerance), so acceptable.

2) Dominant tautomer in aqueous solution
- Agent’s claim: ENOL and KETO are the major forms (≥98% combined); no hemiketal reported.
- Literature: Warfarin exists mainly as cyclic hemiketal diastereomers in water; open-chain 4‑hydroxycoumarin is minor. ([pubs.acs.org](https://pubs.acs.org/doi/10.1021/acs.joc.5b01370?utm_source=openai))
- Assessment: Agent omitted the experimentally supported dominant hemiketal; conclusion is incorrect.

3) Ionization state at pH 7.4
- Agent’s value: 84% deprotonated (total anion).
- Literature-based calculation: Using pKa = 5.05, fraction deprotonated = 10^(7.4−5.05) / (1 + 10^(7.4−5.05)) ≈ 223.9 / 224.9 ≈ 99.6%. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/6470958/?utm_source=openai))
- Absolute error: 99.6% − 84% = 15.6 percentage points.
- Percent error (relative to literature fraction): 15.6/99.6 ≈ 15.7%.
- Score justification: Large deviation; also inconsistent with agent’s own pKa.

4) Protein binding affinity to HSA (Kd at ~pH 7.4)
- Agent’s value: 1.6 µM (−10.1 kcal/mol).
- Literature values:
  • Equilibrium dialysis: K1 = (1.41–1.92)×10^5 M^−1 → Kd ≈ 5–7 µM. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/3969070/?utm_source=openai))
  • Fluorescence (temperatures vary): Ka ~3.5×10^5 M^−1 at 37 °C → Kd ≈ 2.9 µM. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/7132952/?utm_source=openai))
  • ITC (pH 7.13, I = 0.1): Ka = 5.8×10^5 M^−1 → Kd ≈ 1.7 µM. ([onlinelibrary.wiley.com](https://onlinelibrary.wiley.com/doi/abs/10.1562/2006-02-23-RA-811?utm_source=openai))
- Absolute error:
  • vs dialysis 6 µM: |1.6 − 6| = 4.4 µM (73% error).
  • vs ITC 1.7 µM: |1.6 − 1.7| = 0.1 µM (6% error).
- Score justification: Agreement depends on method; agent should have contextualized variability. Claiming “good agreement” without stating assay/conditions is incomplete.

5) Structural reference (PDB)
- Agent’s claim: “2BXD (apo, 2.4 Å).”
- Literature: 2BXD is HSA complexed with warfarin, 3.05 Å resolution. ([rcsb.org](https://www.rcsb.org/structure/2bxd?utm_source=openai))
- Assessment: Factual errors in PDB description.

6) Tautomer reference support
- Tautomerism review with experimental NMR: hemiketal dominance in water; open-chain as minor. ([pubs.acs.org](https://pubs.acs.org/doi/10.1021/acs.joc.5b01370?utm_source=openai))

### Web Search Citations:
1. [Tautomerism of Warfarin: Combined Chemoinformatics, Quantum Chemical, and NMR Investigation | The Journal of Organic Chemistry](https://pubs.acs.org/doi/10.1021/acs.joc.5b01370?utm_source=openai)
2. [Dissolution and ionization of warfarin - PubMed](https://pubmed.ncbi.nlm.nih.gov/6470958/?utm_source=openai)
3. [RCSB PDB - 2BXD: Human serum albumin complexed with warfarin](https://www.rcsb.org/structure/2bxd?utm_source=openai)
4. [Investigations of the effects of ethanol on warfarin binding to human serum albumin | Journal of Biomedical Science](https://link.springer.com/article/10.1007/bf02256617?utm_source=openai)
5. [Dissolution and ionization of warfarin - PubMed](https://pubmed.ncbi.nlm.nih.gov/6470958/?utm_source=openai)
6. [Tautomerism of Warfarin: Combined Chemoinformatics, Quantum Chemical, and NMR Investigation | The Journal of Organic Chemistry](https://pubs.acs.org/doi/10.1021/acs.joc.5b01370?utm_source=openai)
7. [Dissolution and ionization of warfarin - PubMed](https://pubmed.ncbi.nlm.nih.gov/6470958/?utm_source=openai)
8. [Interaction of warfarin with human serum albumin. A stoichiometric description - PubMed](https://pubmed.ncbi.nlm.nih.gov/3969070/?utm_source=openai)
9. [Fluorimetric analysis of the binding of warfarin to human serum albumin. Equilibrium and kinetic study - PubMed](https://pubmed.ncbi.nlm.nih.gov/7132952/?utm_source=openai)
10. [Binding of Warfarin Influences the Acid‐Base Equilibrium of H242 in Sudlow Site I of Human Serum Albumin - Perry - 2006 - Photochemistry and Photobiology - Wiley Online Library](https://onlinelibrary.wiley.com/doi/abs/10.1562/2006-02-23-RA-811?utm_source=openai)
11. [RCSB PDB - 2BXD: Human serum albumin complexed with warfarin](https://www.rcsb.org/structure/2bxd?utm_source=openai)
12. [Tautomerism of Warfarin: Combined Chemoinformatics, Quantum Chemical, and NMR Investigation | The Journal of Organic Chemistry](https://pubs.acs.org/doi/10.1021/acs.joc.5b01370?utm_source=openai)
13. [Tautomerism of Warfarin: Combined Chemoinformatics, Quantum Chemical, and NMR Investigation | The Journal of Organic Chemistry](https://pubs.acs.org/doi/10.1021/acs.joc.5b01370?utm_source=openai)
14. [Dissolution and ionization of warfarin - PubMed](https://pubmed.ncbi.nlm.nih.gov/6470958/?utm_source=openai)
15. [RCSB PDB - 2BXD: Human serum albumin complexed with warfarin](https://www.rcsb.org/structure/2bxd?utm_source=openai)
16. [Binding of Warfarin Influences the Acid‐Base Equilibrium of H242 in Sudlow Site I of Human Serum Albumin - Perry - 2006 - Photochemistry and Photobiology - Wiley Online Library](https://onlinelibrary.wiley.com/doi/abs/10.1562/2006-02-23-RA-811?utm_source=openai)

### Execution:
- **Tools**: submit_tautomer_search_workflow, molecule_lookup
- **Time**: 0.8 min

---
*Evaluated with openai/gpt-5*
